U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Name Type Language
H-gamma4 heavy chain anti-F7a humanized (1-448) [VH (Homo sapiens IGHV4-30-2*07 (92.9%) -(IGHD) -IGHJ4*01 (100%), CDR-IMGT [9.7.15] (26-34.52-58.97-111)) (1-122)-Homo sapiens IGHG4*01 nG4m(a) CH2 L92, G4v5 h P10, G4v10 CH3 L85.1, K88 (CH1 (123-220), hing
Preferred Name English
Sutacimig
INN  
Official Name English
sutacimig [INN]
Common Name English
Immunoglobulin G4 [230-proline,407-leucine,411-lysine,de-C-terminal-lysine], bispecific, anti-(human blood-coagulation factor VIIa) (human-Mus musculus monoclonal 11F2 ?4-chain), disulfide with human-Mus musculus monoclonal 11F2 ?-chain, (228?220?),(231?
Common Name English
immunoglobulin (H-gamma4_L-kappa)_(H-gamma4_L-kappa), anti-[Homo sapiens F7 (coagulation factor 7, blood coagulation factor VII, coagulation serum prothrombin conversion accelerator) activated (F7a, F7A, FVIIa, FVIIA)] and anti-[Homo sapiens TREML1 (trig
Common Name English
Code System Code Type Description
NCI_THESAURUS
C211722
Created by admin on Wed Apr 02 17:55:09 GMT 2025 , Edited by admin on Wed Apr 02 17:55:09 GMT 2025
PRIMARY
CAS
2933972-64-4
Created by admin on Wed Apr 02 17:55:09 GMT 2025 , Edited by admin on Wed Apr 02 17:55:09 GMT 2025
PRIMARY
INN
13275
Created by admin on Wed Apr 02 17:55:09 GMT 2025 , Edited by admin on Wed Apr 02 17:55:09 GMT 2025
PRIMARY
FDA UNII
2QP8468SQP
Created by admin on Wed Apr 02 17:55:09 GMT 2025 , Edited by admin on Wed Apr 02 17:55:09 GMT 2025
PRIMARY